Camille L. Bedrosian

Insider Reports History

Entity
Individual
Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, California
Signature
/s/ Hunter Smith, attorney-in-fact for Camille L. Bedrosian
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Camille L. Bedrosian:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Chief Medical Officer Common Stock 155 K $2.91 M $18.73 Apr 16, 2024 Direct
Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Common Stock 46.7 K $981 K $21.00 Mar 1, 2023 Direct
Crinetics Pharmaceuticals, Inc. Director Common Stock 9.4 K $446 K $47.49 Jun 7, 2024 Direct
RHYTHM PHARMACEUTICALS, INC. Director Common Stock 3 K $117 K $39.10 Jun 21, 2024 Direct
RHYTHM PHARMACEUTICALS, INC. Director Restricted Stock Units 0 $0 $39.10 Jun 21, 2024 Direct
Amylyx Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 120 K Apr 16, 2024 Direct
Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Stock Option (Right to Buy) 24.9 K Mar 1, 2022 Direct
RHYTHM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 14 K Jun 18, 2024 Direct
Crinetics Pharmaceuticals, Inc. Director Stock Option (right to buy) 12.5 K Jun 7, 2024 Direct

Insider Reports Filed by Camille L. Bedrosian

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 21, 2024 2 $0 4 Jun 25, 2024 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
CRNX Crinetics Pharmaceuticals, Inc. Jun 7, 2024 2 $0 4 Jun 11, 2024 Director
AMLX Amylyx Pharmaceuticals, Inc. Apr 16, 2024 2 $0 4 Apr 18, 2024 Chief Medical Officer
AMLX Amylyx Pharmaceuticals, Inc. Nov 27, 2023 2 $0 4 Nov 29, 2023 Chief Medical Officer
AMLX Amylyx Pharmaceuticals, Inc. Nov 27, 2023 0 $0 3 Nov 29, 2023 Chief Medical Officer
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 21, 2023 2 $0 4 Jun 23, 2023 Director
CRNX Crinetics Pharmaceuticals, Inc. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2023 2 -$176 K 4 Mar 3, 2023 EVP and Chief Medical Officer
CRNX Crinetics Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4 Jun 21, 2022 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2022 3 -$188 K 4 Mar 3, 2022 EVP and Chief Medical Officer
RARE Ultragenyx Pharmaceutical Inc. Jan 30, 2022 1 -$110 K 4 Feb 1, 2022 EVP and Chief Medical Officer
RARE Ultragenyx Pharmaceutical Inc. Oct 14, 2021 1 -$29.1 K 4 Oct 18, 2021 EVP and Chief Medical Officer
RARE Ultragenyx Pharmaceutical Inc. Sep 1, 2021 6 -$226 K 4 Sep 2, 2021 EVP and Chief Medical Officer
CRNX Crinetics Pharmaceuticals, Inc. Jun 22, 2021 1 $0 4 Jun 23, 2021 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 9, 2021 1 $0 4 Jun 11, 2021 Director
RARE Ultragenyx Pharmaceutical Inc. May 6, 2021 1 -$41.4 K 4 May 10, 2021 EVP and Chief Medical Officer